Neuroscience
Positron Emission Tomography
100%
Fluorine-18
53%
Alzheimer's Disease
53%
Positron Emission Tomography
47%
Histamine H1 Receptor
36%
In Vivo
30%
Doxepin
27%
Receptor Occupancy
27%
Donepezil
21%
Amyloid Protein
20%
Antihistamines
15%
Pharmacokinetics
14%
Acetylcholinesterase
14%
Placebo
11%
Benadryl
11%
Diphenhydramine
11%
Bepotastine
11%
Somnolence
9%
Metabolic Pathway
8%
Progressive Supranuclear Palsy
8%
Cetirizine
8%
Raclopride
7%
Blood Plasma
6%
Gyri
6%
In Vitro
6%
Dopamine Release
5%
Benzoxazoles
5%
Mild Cognitive Impairment
5%
Astrogliosis
5%
Monoamine Oxidase B
5%
Magnetic Resonance Imaging
5%
Pharmacology, Toxicology and Pharmaceutical Science
Carbon 11
23%
Histamine H1 Receptor
23%
Polyethylene Terephthalate
20%
Fluorine 18
19%
Doxepin
18%
Antihistaminic Agent
15%
Diphenhydramine
11%
Bepotastine
11%
Placebo
9%
Hypoxia
8%
Alzheimer's Disease
8%
Cetirizine
8%
Neoplasm
8%
Somnolence
8%
Tracer
6%
Binding Potential
6%
Normal Human
5%
Medicine and Dentistry
Positron Emission Tomography
27%
Polyethylene Terephthalate
18%
Fluorine-18
15%
Carbon 11
12%
Radioactive Tracer
11%
Fluorodeoxyglucose F 18
8%
Drug-Eluting Stent
8%
Progressive Supranuclear Palsy
8%
Amyloid Protein
8%
Tibia
7%
Bone Remodeling
7%
Implant
6%
Alzheimer's Disease
5%